230 related articles for article (PubMed ID: 13601)
1. Comparative evaluation of neuromuscular blockade and reversibility of AH 8165 and pancuronium bromide in man.
Camu F; Sanders M; D'Hollander A
Acta Anaesthesiol Belg; 1976; 27 suppl():80-5. PubMed ID: 13601
[TBL] [Abstract][Full Text] [Related]
2. Interaction of verapamil with gallamine and pancuronium and reversal of combined neuromuscular blockade with neostigmine and edrophonium.
Wali FA
Eur J Anaesthesiol; 1986 Sep; 3(5):385-93. PubMed ID: 3780695
[TBL] [Abstract][Full Text] [Related]
3. Neuromuscular blocking action of vecuronium in the dog and its reversal by neostigmine.
Jones RS
Res Vet Sci; 1985 Mar; 38(2):193-6. PubMed ID: 2860709
[TBL] [Abstract][Full Text] [Related]
4. Recovery of neuromuscular function after atracurium and pancuronium maintenance of pancuronium block.
Whalley DG; Lewis B; Bedocs NM
Can J Anaesth; 1994 Jan; 41(1):31-5. PubMed ID: 8111941
[TBL] [Abstract][Full Text] [Related]
5. Twitch depression and train-of-four ratio after antagonism of pancuronium with edrophonium, neostigmine, or pyridostigmine.
Donati F; Ferguson A; Bevan DR
Anesth Analg; 1983 Mar; 62(3):314-6. PubMed ID: 6299135
[TBL] [Abstract][Full Text] [Related]
6. Clinical neuromuscular pharmacology of AH 8165 D, an azobis-arylimidazo-pyridinium-compound.
Schuh FT
Anaesthesist; 1975 Apr; 24(4):151-6. PubMed ID: 237423
[TBL] [Abstract][Full Text] [Related]
7. Comparative evaluation of the neuromuscular and cardiovascular effects of pipecuronium, pancuronium, atracurium, and vecuronium under isoflurane anesthesia.
Larijani GE; Gratz I; Minassian SS; Hughes DL; Afshar M; Karayannis BN
Pharmacotherapy; 1992; 12(4):278-82. PubMed ID: 1355599
[TBL] [Abstract][Full Text] [Related]
8. Neuromuscular blocking effects of vecuronium and pancuronium during halothane anaesthesia.
Engbaek J; Ording H; Viby-Mogensen J
Br J Anaesth; 1983 Jun; 55(6):497-500. PubMed ID: 6134535
[TBL] [Abstract][Full Text] [Related]
9. Combination of pancuronium and metocurine: neuromuscular and hemodynamic advantages over pancuronium alone.
Lebowitz PW; Ramsey FM; Savarese JJ; Ali HH; deBros FM
Anesth Analg; 1981 Jan; 60(1):12-7. PubMed ID: 7192943
[TBL] [Abstract][Full Text] [Related]
10. Clinical evaluation of a new non-depolarising muscle relaxant.
Ungerer MJ; Erasmus FR
S Afr Med J; 1974 Dec; 48(61):2561-4. PubMed ID: 4281529
[No Abstract] [Full Text] [Related]
11. Clinical experience with ORG NC45 (norcuron) as the sole muscle relaxant.
Williams A; Gyasi H; Melloni C; Bevan DR
Can Anaesth Soc J; 1982 Nov; 29(6):567-72. PubMed ID: 6128068
[TBL] [Abstract][Full Text] [Related]
12. Neostigmine, pyridostigmine, and edrophonium as antagonists of pancuronium.
Ferguson A; Egerszegi P; Bevan DR
Anesthesiology; 1980 Nov; 53(5):390-4. PubMed ID: 7425377
[TBL] [Abstract][Full Text] [Related]
13. [Antagonism to neuromuscular effect of subcutaneous administration of pancuronium by neostigmine].
Iwasaki H; Igarashi M; Omori H; Omote K; Namiki A
Masui; 1994 Jun; 43(6):885-8. PubMed ID: 8072147
[TBL] [Abstract][Full Text] [Related]
14. Use of 100-Hertz tetanus as an index of recovery from pancuronium-induced non-depolarizing neuromuscular blockade.
Kopman AF; Epstein RH; Flashburg MH
Anesth Analg; 1982 May; 61(5):439-41. PubMed ID: 7199868
[TBL] [Abstract][Full Text] [Related]
15. Clinical pharmacology of ORG NC45 (NorcuronTM): a new nondepolarizing muscle relaxant.
Fahey MR; Morris RB; Miller RD; Sohn YJ; Cronnelly R; Gencarelli P
Anesthesiology; 1981 Jul; 55(1):6-11. PubMed ID: 6113794
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of the action of pipecuronium bromide in patients under halothane anesthesia--a comparison with pancuronium bromide regarding their neuromuscular blocking and cardiovascular effects].
Sugai N; Yajima C; Numata K; Irimada T; Hashimoto Y; Itagaki T; Katsumata N; Suzuki H; Aoki T; Fukushima K
Masui; 1990 Mar; 39(3):293-300. PubMed ID: 2161058
[TBL] [Abstract][Full Text] [Related]
17. Reversal of combination nondepolarized neuromuscular block.
Vitez TS; Difrancesco LV
Anesth Analg; 1983 Dec; 62(12):1081-2. PubMed ID: 6228170
[TBL] [Abstract][Full Text] [Related]
18. Edrophonium and neostigmine for reversal of the neuromuscular blocking effect of vecuronium.
Engbaek J; Ording H; Ostergaard D; Viby-Mogensen J
Acta Anaesthesiol Scand; 1985 Jul; 29(5):544-6. PubMed ID: 2863917
[TBL] [Abstract][Full Text] [Related]
19. Potentiation of neuromuscular blockade in man produced by combinations of pancuronium and metocurine or pancuronium and d-tubocurarine.
Lebowitz PW; Ramsey FM; Savarese JJ; Ali HH
Anesth Analg; 1980 Aug; 59(8):604-9. PubMed ID: 7190795
[TBL] [Abstract][Full Text] [Related]
20. Dose-response relation, neuromuscular blocking action, intubation conditions, and cardiovascular effects of Org 9273, a new neuromuscular blocking agent.
van den Broek L; Lambalk LM; Richardson FJ; Wierda JM
Anesth Analg; 1991 Jun; 72(6):811-6. PubMed ID: 1674648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
